英文名稱 | Nemorubicin | Methoxymorpholinyldoxorubicin | PNU 152243 | PNU-152243A | | DMM Dox | MMRDX | FCE 23762 | PNU 152243 |
---|---|
中文名稱 | 奈莫柔比星 |
CAS號 | 108852-90-0 |
分子式 | C32H37NO13 |
分子量 | 643.64 |
外觀 | Orange to reddish brown powder |
儲存條件 | 4°C, protect from light |
英文名稱 | Nemorubicin | Methoxymorpholinyldoxorubicin | PNU 152243 | PNU-152243A | | DMM Dox | MMRDX | FCE 23762 | PNU 152243 |
---|---|
中文名稱 | 奈莫柔比星 |
CAS號 | 108852-90-0 |
分子式 | C32H37NO13 |
分子量 | 643.64 |
外觀 | Orange to reddish brown powder |
儲存條件 | 4°C, protect from light |
Nemorubicin (Methoxymorpholinyl doxorubicin) is a Doxorubicin derivative with potent antitumor activity. Nemorubicin is highly cytotoxic to a variety of tumor cell lines presenting a multidrug-resistant phenotype. Nemorubicin not only intercalate into the duplex DNA, but also result in significant ligands for G-quadruplex DNA segments, stabilizing their structure. Nemorubicin requirs an intact nucleotide excision repair (NER) system to exert its activity .
PMID: 15746066 DOI: 10.1158/1078-0432.CCR-04-1845
PMID: 20868484 PMCID: PMC2955619 DOI: 10.1186/1476-4598-9-259
PMID: 18671948 DOI: 10.1016/j.bcp.2008.07.003
Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.
PMID: 19011599 PMCID: PMC2669851 DOI: 10.1038/cgt.2008.93